Assignee
MEDIGENEBIO CORP
KR·1 granted patent·2 pending applications·0 citations·filing 2014–2019
Top patents by PatentIndex Score
3 records- 0149US2014351964A1Transgenic mouse model for developing enzyme replacement therapy for iduronate-2-sulfatase deficiency syndromeMEDIGENEBIO CORP·Filed 2014·Application pending·0 cites
- 0240US9795653B2Use of inhalable powder formulation comprising growth hormone for preventing or treating NMDA receptor hypofunction-related diseasesMEDIGENEBIO CORP·Filed 2014·Granted Oct 24, 2017·0 cites·5 claims
- 0324US2021213109A1Method and composition for treating hunter syndrome through cerebral lateral ventricle administrationMEDIGENEBIO CORP·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEDIGENEBIO CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →